126 related articles for article (PubMed ID: 34163209)
1. TRAP1 Shows Clinical Significance in the Early Diagnosis of Small Cell Lung Cancer.
Li X; Li X; Chen S; Wu Y; Liu Y; Hu T; Huang J; Yu J; Pei Z; Zeng T; Tan L
J Inflamm Res; 2021; 14():2507-2514. PubMed ID: 34163209
[TBL] [Abstract][Full Text] [Related]
2. MAD2 Combined with Mitotic Spindle Apparatus (MSA) and Anticentromere Antibody (ACA) for Diagnosis of Small Cell Lung Cancer (SCLC).
Wu Y; Tan L; Chen J; Li H; Ying H; Jiang Y; Wu Q; Yu G; Tian Y; Yu J; Zeng T; Yan L; Liu C
Med Sci Monit; 2018 Oct; 24():7541-7547. PubMed ID: 30346937
[TBL] [Abstract][Full Text] [Related]
3. The value of serum TRAP1 in diagnosing small cell lung cancer and tumor immunity.
Tan LM; Ke SP; Li X; Ouyang TL; Yu LQ; Yu JL; Wang YK; Yang QJ; Li XH; Yu X; Li H; Hu XY
Exp Biol Med (Maywood); 2023 Feb; 248(3):201-208. PubMed ID: 36598065
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC).
Tan L; Zhang Y; Jiang Y; Li H; Chen J; Ming F; Wang W; Yu J; Zeng T; Tian Y; Wu Y
Am J Clin Exp Immunol; 2017; 6(2):21-26. PubMed ID: 28337388
[TBL] [Abstract][Full Text] [Related]
5. Application of collagen triple helix repeat containing-1 and mitotic spindle apparatus antibody in small cell lung cancer diagnosis.
Liu Y; Hu T; Li X; Li X; Yu J; Wu Y; Chen S; Tan L
J Clin Lab Anal; 2022 May; 36(5):e24412. PubMed ID: 35385156
[TBL] [Abstract][Full Text] [Related]
6. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.
Sisinni L; Maddalena F; Condelli V; Pannone G; Simeon V; Li Bergolis V; Lopes E; Piscazzi A; Matassa DS; Mazzoccoli C; Nozza F; Lettini G; Amoroso MR; Bufo P; Esposito F; Landriscina M
J Pathol; 2017 Sep; 243(1):123-134. PubMed ID: 28678347
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
8. Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps.
Müller SJ; Khadhraoui E; Neef NE; Riedel CH; Ernst M
BMC Med Imaging; 2021 Apr; 21(1):70. PubMed ID: 33858368
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.
Chen BT; Chen Z; Ye N; Mambetsariev I; Fricke J; Daniel E; Wang G; Wong CW; Rockne RC; Colen RR; Nasser MW; Batra SK; Holodny AI; Sampath S; Salgia R
Front Oncol; 2020; 10():593. PubMed ID: 32391274
[TBL] [Abstract][Full Text] [Related]
10. Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Xu C; Wang Y; Yuan Q; Wang W; Chi C; Zhang Q; Zhang X
J Cell Mol Med; 2019 Mar; 23(3):2077-2082. PubMed ID: 30635982
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kondo S; Kaji M
Lung Cancer; 2011 Oct; 74(1):124-31. PubMed ID: 21376419
[TBL] [Abstract][Full Text] [Related]
12. Expression of tumor necrosis factor receptor-associated protein 1 and its clinical significance in kidney cancer.
Si T; Yang G; Qiu X; Luo Y; Liu B; Wang B
Int J Clin Exp Pathol; 2015; 8(10):13090-5. PubMed ID: 26722505
[TBL] [Abstract][Full Text] [Related]
13. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.
Agorreta J; Hu J; Liu D; Delia D; Turley H; Ferguson DJ; Iborra F; Pajares MJ; Larrayoz M; Zudaire I; Pio R; Montuenga LM; Harris AL; Gatter K; Pezzella F
Mol Cancer Res; 2014 May; 12(5):660-9. PubMed ID: 24567527
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of heat shock protein 90 isoforms in small cell lung cancer.
Lee JH; Kang KW; Kim JE; Hwang SW; Park JH; Kim SH; Ji JH; Kim TG; Nam HY; Roh MS; Lee EH; Park MI; Kim MS; Lee HW
Int J Clin Exp Pathol; 2015; 8(8):9487-93. PubMed ID: 26464709
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of vascular endothelial growth factor in patients with small cell lung cancer].
Liu J; Zhu X
Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):406-10. PubMed ID: 21126410
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
Yang J; Li R; Li A
Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of ProGRP for small cell lung cancer in different stages.
Dong A; Zhang J; Chen X; Ren X; Zhang X
J Thorac Dis; 2019 Apr; 11(4):1182-1189. PubMed ID: 31179060
[TBL] [Abstract][Full Text] [Related]
18. Expression of placental growth factor gene in lung cancer.
Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK
Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic value of ProGRP in lung cancer.
Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T
Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
